Canadian Organ Replacement Register.Annual Report 2001. Volume 1: Dialysis and Renal Transplantation.Ottawa: Canadian Institute for Health Information; 2001.
2.
LinY.P., YuW.C., HsuT.L., DingP.Y., YangW.C., ChenC.H.The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients.Am J Kidney Dis2003; 42: 990–9.
3.
WangA.Y., LamC.W., YuC.M., WangM., ChanI.H., ZhangY.N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.J Am Soc Nephrol2007; 18: 321–30.
4.
KoningsC.J., KoomanJ.P., SchonckM., van KreelB., HeidendalG.A., CheriexE.C.Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients.Perit Dial Int2003; 23: 184–90.
5.
ItobiE., StroudM., EliaM.Impact of oedema on recovery after major abdominal surgery and potential value of multifrequency bioimpedance measurements.Br J Surg2006; 93: 354–61.
6.
PiccoliA., RossiB., PillonL., BuccianteG.A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph.Kidney Int1994; 46: 534–9.
7.
HeafJ.CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate.Ren Fail1995; 17: 575–87.
8.
DumlerF.Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis.ASAIO J2003; 49: 282–6.
9.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Quantifying co-morbidity in peritoneal dialysis patients and its relationship to other predictors of survival.Nephrol Dial Transplant2002; 17: 1085–92.
10.
EniaG., SicusoC., AlatiG., ZoccaliC.Subjective global assessment of nutrition in dialysis patients.Nephrol Dial Transplant1993; 8: 1094–8.
11.
BIVA Software, 2002. Department of Medical and Surgical Sciences, University of PadovaPadova, Italy. Available from e-mail: apiccoli@unipd. it [computer program].
12.
KuhlmannM.K., ZhuF., SeibertE., LevinN.W.Bioimpedance, dry weight and blood pressure control: new methods and consequences.Curr Opin Nephrol Hypertens2005; 14: 543–9.
13.
VickeryS., LambE.J., JohnR.I., AbbasN.A., WebbM.C., PriceC.P.Use of amino-terminal pro-B-type natriuretic peptide to predict coronary disease.Am J Kidney Dis2006; 47: 194–5.
14.
AlehagenU., LindstedtG., ErikssonH., DahlstromU.Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.Clin Chem2003; 49: 1337–46.
15.
MallamaciF., ZoccaliC., ParlongoS., TripepiG., BenedettoF.A., CutrupiS.Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.Kidney Int2002; 62: 1884–90.
16.
MushnickR., FeinP.A., MittmanN., GoelN., ChattopadhyayJ., AvramM.M.Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients.Kidney Int Suppl2003; 87: S53–6.
17.
ZoccaliC., MallamaciF., BenedettoF.A., TripepiG., ParlongoS., CataliottiA.Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.J Am Soc Nephrol2001; 12: 1508–15.